ECNet-guided selection of higher-order TEM-1 variants
ECNet integrated evolutionary context with learned sequence representations to prioritize previously untested higher-order TEM-1 variants. The authors constructed and measured 37 selected variants under ampicillin selection, using relative resistance as an enzyme-fitness proxy. The assays do not imply clinical treatment outcomes, and the reported group of 37 should not be read as showing that every variant improved.
Technology: ECNet evolutionary-context-integrated deep-learning framework
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Thirty-seven previously untested higher-order TEM-1 variants selected with ECNet were constructed and experimentally measured under ampicillin selection against wild-type and study controls. The study uses relative resistance as an enzyme-fitness proxy.
- Still unknown: The bounded entry does not imply that all 37 variants improved equally, does not establish clinical outcomes, and makes no claim of independent sequence novelty beyond the authors’ screened literature.
- AI role: ECNet integrated evolutionary context and a learned representation to prioritize higher-order TEM-1 variants for experimental construction and ampicillin-selection measurements.
Evidence sources: https://www.nature.com/articles/s41467-021-25976-8 · https://zhaogroup.web.illinois.edu/publications/HZ370.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary Nature indexed article and author-hosted full text; official bioRxiv API checked and identified the previously associated preprint DOI as a different paper..
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.